Back To Index
<<
Back To Templates
Template
CDA LabeledDrug
Id
2.16.840.1.113883.10.12.310
ref
ad1bbr-
Effective Date
2005‑09‑07
Status
Active
Version Label
Name
CDALabeledDrug
Display Name
CDA LabeledDrug
Description
Template CDA LabeledDrug (prototype, directly derived from POCD_RM000040 MIF)
Classification
CDA Entry Level Template
Open/Closed
Open (other than defined elements are allowed)
Used by / Uses
Used by 0 transactions and 38 templates, Uses 0 templates
Used by
as
Name
Version
2.16.840.1.113883.10.12.312
Include
CDA ManufacturedProduct
2005‑09‑07
2.16.840.1.113883.10.12.308
CDA SubstanceAdministration
2005‑09‑07
Circular reference found with 2.16.840.1.113883.10.12.308, please check
2.16.840.1.113883.10.12.300
CDA Clinical Statement
2005‑09‑07
Circular reference found with 2.16.840.1.113883.10.12.300, please check
2.16.840.1.113883.10.12.201
CDA Section
2005‑09‑07
Circular reference found with 2.16.840.1.113883.10.12.201, please check
2.16.840.1.113883.10.12.202
CDA StructuredBody
2005‑09‑07
2.16.840.1.113883.10.12.112
CDA component
2005‑09‑07
2.16.840.1.113883.3.1937.777.63.10.17
Prescrizione farmaceutica
2022‑06‑22 16:53:44
2.16.840.1.113883.3.1937.777.63.10.153
Allergie (RAP) (Allergie(RAP))
2022‑09‑22 15:46:20
2.16.840.1.113883.3.1937.777.63.10.16
CDA ClinicalDocument (with StructuredBody)
2022‑06‑21 10:58:46
2.16.840.1.113883.3.1937.777.63.10.22
CDA Section
2022‑06‑23 14:04:37
2.16.840.1.113883.3.1937.777.63.10.237
CDA ClinicalDocument (with StructuredBody)
2022‑09‑30 10:06:14
2.16.840.1.113883.10.12.301
CDA Act
2005‑09‑07
2.16.840.1.113883.10.12.302
CDA Encounter
2005‑09‑07
2.16.840.1.113883.10.12.303
CDA Observation
2005‑09‑07
2.16.840.1.113883.10.12.304
CDA ObservationMedia
2005‑09‑07
2.16.840.1.113883.10.12.305
CDA Organizer
2005‑09‑07
2.16.840.1.113883.10.12.306
CDA Procedure
2005‑09‑07
2.16.840.1.113883.10.12.307
CDA RegionOfInterest
2005‑09‑07
2.16.840.1.113883.10.12.309
CDA Supply
2005‑09‑07
Circular reference found with 2.16.840.1.113883.10.12.309, please check
2.16.840.1.113883.2.9.10.1.5.4.2
Terapia farmacologica somministrata (LDO)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.5.4.4
Terapia farmacologica richiesta (LDO)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.1
Motivo della visita (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.10
Terapia Farmacologica Consigliata (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.2
Terapia Farmacologica In Atto (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.3
Prestazioni Amministrative Eseguite (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.4
Procedura Operativa Eseguita Procedure (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.5
Procedura Operativa Eseguita SubstanceAdministration (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.6
Procedura Operativa Eseguita Observation (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.7
Procedura Operativa Eseguita Act (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.8
Diagnosi (RSA)
2018‑04‑11
2.16.840.1.113883.2.9.10.1.9.4.9
Accertamenti e Controlli Consigliati (RSA)
2018‑04‑11
2.16.840.1.113883.3.1937.777.63.10.140
CDA Procedure RAP
2022‑09‑21 16:39:15
2.16.840.1.113883.3.1937.777.63.10.146
Tipo campione RAP
2022‑09‑22 08:56:32
2.16.840.1.113883.3.1937.777.63.10.147
Procedura di Dissezione del campione RAP (Procedura_dissezione_campione_RAP)
2022‑09‑22 09:49:22
2.16.840.1.113883.3.1937.777.63.10.191
Oggetti correlati - Oss. Macro. - RAP (Oggetti correlati - Oss. Macro. - RAP)
2022‑09‑26 17:34:38
2.16.840.1.113883.3.1937.777.63.10.208
Oggetti correlati - Oss. Micro. - RAP (Oggetti correlati - Oss. Micro. - Oggetti correlati - Oss. Micro. - RAPRAP)
2022‑09‑27 12:28:16
2.16.840.1.113883.3.1937.777.63.10.234
Dimensione cellule tumorali isolate (dimCelluleTumoraliIsolate)
2022‑09‑27 16:24:05
2.16.840.1.113883.3.1937.777.63.10.25
Esenzioni Applicate
2022‑06‑23 14:45:56
Expand All
Collapse All
Item
DT
Card
Conf
Description
Label
hl7:manufacturedLabeledDrug
(CDA
rug)
@classCode
0 … 1
F
MMAT
@determinerCode
0 … 1
F
KIND
hl7:code
CE
0 … 1
(CDA
rug)
CONF
shall be drawn from concept domain "DrugEntity"
hl7:name
EN
0 … 1
(CDA
rug)